These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1111545)

  • 1. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase. II. Time-dependent inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1974 Feb; 23(3):629-36. PubMed ID: 4822747
    [No Abstract]   [Full Text] [Related]  

  • 3. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for a specific monoamine oxidase associated with sympathetic nerves.
    Goridis C; Neff NH
    Neuropharmacology; 1971 Sep; 10(5):557-64. PubMed ID: 5126693
    [No Abstract]   [Full Text] [Related]  

  • 5. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous peripheral leakage of pargyline on intracerebroventricular administration.
    Ali B; Parmar SS; Seth PK; Brumleve SJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1083-6. PubMed ID: 4760882
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the monoamine oxidase of monkey brain.
    Oommen A; Balasubramanian AS
    J Neurochem; 1977 Mar; 28(3):645-54. PubMed ID: 16088
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase activity of rat spinal cord after transection.
    Goridis C; Meek JL; Neff NH
    Life Sci I; 1972 Sep; 11(18):861-6. PubMed ID: 4511739
    [No Abstract]   [Full Text] [Related]  

  • 11. Compounds with potential enzyme inhibitory acitivity. Hydroxylamine analogs of 2-propynylamine.
    Moore DH; Cannon JG; McIsaac WM; Ho BT
    J Med Chem; 1969 Jan; 12(1):45-8. PubMed ID: 5304104
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on monoamine oxidase. (Report XXV). Effects of alcohols on beef liver mitochondrial monoamine oxidase.
    Kurosawa Y
    Jpn J Pharmacol; 1974 Oct; 24(5):787-95. PubMed ID: 4156379
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of monoamine oxidases in sympathetic nerve and pineal gland.
    Yang HY; Goridis C; Neff NH
    J Neurochem; 1972 May; 19(5):1241-50. PubMed ID: 5025123
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain.
    Campbell IC; Robinson DS; Lovenberg W; Murphy DL
    J Neurochem; 1979 Jan; 32(1):49-55. PubMed ID: 32233
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
    Huleatt PB; Khoo ML; Chua YY; Tan TW; Liew RS; Balogh B; Deme R; Gölöncsér F; Magyar K; Sheela DP; Ho HK; Sperlágh B; Mátyus P; Chai CL
    J Med Chem; 2015 Feb; 58(3):1400-19. PubMed ID: 25627172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). II. Comparison of M & B 9302 inhibition with that of iproniazid.
    Hall DW; Logan BW
    Biochem Pharmacol; 1969 Aug; 18(8):1955-9. PubMed ID: 5811628
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.